Episode Details
Back to Episodes
Theory & Insights, the Impact of Articificial Intelligence & Large Language Models on Pharma | Executive Dose
Episode 2309
Published 5 months, 1 week ago
Description
In this episode of Theory & Insights, we bring together two thought leaders at the intersection of healthcare innovation and pharmaceutical manufacturing — John Nosta, renowned AI and technology theorist and founder of NostaLab, and Stephen Beckman, CEO of YARAL Pharma, a rising force in U.S. generics. Together, they dive into the evolving impact of Artificial Intelligence (AI) and Large Language Models (LLMs) on pharmaceutical manufacturing.
The discussion covers the promise and peril of AI in reshaping everything from R&D to regulatory pathways, as well as the ethics, economics, and operational shifts that could redefine the industry in the next decade. This is a must-listen for pharma execs, digital health strategists, and technology innovators looking to understand what’s next.
The discussion covers the promise and peril of AI in reshaping everything from R&D to regulatory pathways, as well as the ethics, economics, and operational shifts that could redefine the industry in the next decade. This is a must-listen for pharma execs, digital health strategists, and technology innovators looking to understand what’s next.